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The first lineage choice in mammalian embryogen-
esis is that between the trophectoderm, which gives
rise to the trophoblast of the placenta, and the inner
cell mass, from which is derived the embryo proper
and the yolk sac. The establishment of these lineages
is preceded by the inside-versus-outside positioning
of cells in the early embryo and stochastic expres-
sion of key transcription factors, which is then
resolved into lineage-restricted expression. The reg-
ulatory inputs that drive this restriction and how they
relate to cell position are largely unknown. Here, we
show an unsuspected role of Notch signaling in regu-
lating trophectoderm-specific expression of Cdx2 in
cooperation with TEAD4. Notch activity is restricted
to outer cells and is able to influence positional allo-
cation of blastomeres, mediating preferential locali-
zation to the trophectoderm. Our results show that
multiple signaling inputs at preimplantation stages
specify the first embryonic lineages.
INTRODUCTION
Upon fertilization, the unicellular mammalian zygote undergoes a
series of equal cell divisions that in 4 days produces a 60- to 100-
cell blastocyst, in which the first embryonic lineages—the tro-
phectoderm (TE) and the inner cell mass (ICM)—have been
established (Stephenson et al., 2012). How this initial lineage
choice occurs and what genetic components constitute the sys-
tem that controls this process have been actively studied for the
past 20 years. Key transcriptional regulators of these early line-410 Developmental Cell 30, 410–422, August 25, 2014 ª2014 Elsevieages identified in the mammalian preimplantation embryo
include OCT4, NANOG, and SOX2 for the ICM and CDX2 for
the TE (Cockburn and Rossant, 2010). These factors determine
blastocyst lineages, but the onset of their expression is stochas-
tic (Dietrich and Hiiragi, 2007), and later restriction to a particular
cell type occurs as a downstream effect of earlier events related
to the position of blastomeres in the embryo (Rossant and Tam,
2009).
This process is believed to involve differences in polarity and
adhesion between inner and outer cells that are related to differ-
ential activation of the Hippo signaling pathway (Hirate et al.,
2013; Nishioka et al., 2009), resulting in sustained and restricted
expression of genes, such as Cdx2 in the outer cells of the future
trophectoderm (Cockburn and Rossant, 2010). Hippo signaling
is switched off in outer cells, leading to nuclear localization of
the transcriptional coactivator YAP, which can then activate
downstream target genes through interaction with the transcrip-
tion factor TEAD4. Embryos lacking Tead4 fail to develop the TE,
and Cdx2 expression is not maintained (Nishioka et al., 2008;
Yagi et al., 2007). Correspondingly, overexpression of LATS2 ki-
nase (an activator of Hippo) reduces expression of CDX2 in outer
cells, whereas embryos lacking Lats1 and Lats2 express CDX2 in
inner cells (Lorthongpanich et al., 2013; Nishioka et al., 2009).
Similar results are obtained when other components of the
pathway, such as Nf2 and Amot, are disrupted (Cockburn
et al., 2013; Hirate et al., 2013). How these components are inte-
grated to fully define lineage restriction in the blastocyst is largely
unknown, and additional inputs remain to be identified (Wenne-
kamp et al., 2013). Reconstruction of this process will require
detailed understanding of the transcriptional control of the key
lineage regulators acting in the preimplantation embryo.
With this aim in mind, we have searched for cis-regulatory
elements responsible for trophectoderm-restricted expression
of Cdx2, and through the analysis of one such enhancer, we
have uncovered a role of the Notch signaling pathway. We findr Inc.
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Analysis of double mutants for Tead4 and the Notch effector
Rbpj shows that the Notch and Hippo pathways converge on
Cdx2 to activate its expression in the trophectoderm, uncovering
an unexpected role for Notch signaling during preimplantation
development (Souilhol et al., 2006). Furthermore, we show
that forced activation of Notch directs blastomeres to the
trophectoderm.
RESULTS
Characterization of a Trophectoderm-Specific
Enhancer from Cdx2
Bymeans of transient transgenic analysis in mouse preimplanta-
tion embryos, we identified a cis-regulatory element located 50 of
Cdx2 that drives reporter expression in the trophectoderm (TE) of
the blastocyst (Figures S1A and S1B available online). Using
fragment #3 of this TE enhancer (TEE) (Figures S1A and S1B)
linked to a H2B-mRFP reporter gene, we then generated several
transgenic lines for further study. The reporter is only occasion-
ally active in a few cells at the eight-cell stage (Figure 1A), and
upon compaction, it starts to be present in the outer cells of
the morula (Figure 1B), attaining strong activity at the 16-cell
stage (Figure 1C). At the blastocyst stage, TEE-driven reporter
activity is localized throughout the TE and excluded from the
ICM (Figure 1D). We also generated TEE transgenic lines using
a lacZ reporter, which behaved identically to the H2B-mRFP
reporter lines (Figure S1C). Tracking blastomeres in the mRFP
reporter lines up to the 3.5 dpc blastocyst revealed a steady tem-
poral increase in the number expressing mRFP (Figure 1E).
Reporter activity in either the mRFP or lacZ TEE lines was found
throughout the TE, although occasionally we detected cells with
lower levels of expression. Immunohistochemical analysis of
the association between reporter activity and endogenous
CDX2 showed concordant expression in >75% of blastomeres
(CDX2+/TEE+, CDX/TEE; Figure 1F), confirming that TEE
activity closely matches the expression of CDX2 at preimplanta-
tion stages (Dietrich and Hiiragi, 2007; Strumpf et al., 2005).
The TE Enhancer Is Active in Cdx2 and Tead4 Mutant
Blastocysts
We next aimed to determine the upstream regulatory factors
acting on the TEE to restrict Cdx2 expression. To date, the
only transcription factors proposed to regulate Cdx2 in the tro-
phectoderm are CDX2 itself, through an autoregulatory loop
(Niwa et al., 2005), and TEAD4, acting together with YAP down-
stream of the Hippo pathway (Nishioka et al., 2009). To test
whether these factors are required for TEE activity in the blasto-
cyst, we first examined homozygous Cdx2 knockout (KO) mice
(Strumpf et al., 2005) containing the mRFP reporter, finding
that TEE reporter activity was still restricted to the TE (Figures
S2A and S2B) and that the number of positive cells was the
same as in wild-type (WT) littermates (Figures S2C and S2D).
We next analyzed the regulation of the TEE by the Hippo
pathway. To check to which extent the TEE was a YAP/TEAD
response element, we bred the mRFP reporter line into the
Tead4 KO background (Nishioka et al., 2008). The TEE was fully
active in homozygous Tead4/ 3.5 dpc embryos (Figures 2A
and 2B) and even conserved preferential activity in outerDevelopblastomeres (Figure 2B). Consistent with previous reports
(Kaneko and DePamphilis, 2013; Nishioka et al., 2008), we also
found that some Tead4/ embryos retained CDX2 expression
(Figure 2C), suggesting that additional inputs are necessary
for the early expression of Cdx2. Furthermore, we did not detect
significant differences in total cell number or in mRFP+ blasto-
meres per embryo between wild-type, heterozygous, and homo-
zygous embryos (Figures S2E and S2F), precluding an effect of
the loss of Tead4 on the total number of cells in which the TEE
is active.
To investigate this further, we took advantage of the 5TVER7
embryonic stem (ES) cell line, which stably expresses a tamox-
ifen-inducible active TEAD4 protein (Tead4VP16ER) (Nishioka
et al., 2009). Upon tamoxifen induction, these cells activate
Cdx2 expression and acquire a trophoblast stem (TS) cell pheno-
type. We transfected 5TVER7 cells with the TEE or with the Oct4
distal enhancer (Oct4DE) (Yeom et al., 1996) as a control and
treated them with tamoxifen in TS culture medium (Tanaka
et al., 1998). After 48 hr in these conditions, quantitative PCR
(qPCR) analysis showed robust activation of Cdx2 and downre-
gulation of Oct4, accompanied by a strong decrease in Oct4DE
activity (Figures 2D and 2E). Despite the forced expression of the
active TEAD4 form, we did not observe a strong effect on TEE
activity compared with culture in ES cell culture medium without
tamoxifen, although treatment did increase its activity slightly but
significantly compared with control empty vector (Figure 2E).
These experiments provide additional evidence that TEAD4
alone is not sufficient to fully activate the TEE. We next tested
if forced activation of the Hippo pathway in outer cells would
silence the TEE. Embryos of the mRFP-TEE line were injected
with Lats2 RNA, which turns the Hippo pathway on and results
in decreased expression of CDX2 in outer cells (Nishioka et al.,
2009). This did not influence the expression of the reporter in
the TE (Figure 2F), confirming that the TEE does not respond
exclusively to the activation state of the Hippo pathway in the
blastocyst.
The Notch Signaling Pathway Is Active in the
Trophectoderm of the Blastocyst
To identify other transcriptional inputs acting on the TEE, we
searched the minimal 1.3 kb sequence active in the TE (fragment
#6; Figures S1A andS1B) for putative transcription factor binding
sites; this search detected four high-confidence sites for RBPJ
(Tun et al., 1994), the transcriptional effector of the Notch
pathway. RBPJ acts together with the intracellular domain of
Notch, the product of the proteolytic cleavage of the receptor
upon its activation that is then translocated to the nucleus (Ko-
pan and Ilagan, 2009). Additionally, we detected two putative
TEAD binding sites (Anbanandam et al., 2006) (Figure S3A).
This observation suggested that Notch could have a role in
development of the blastocyst, but to date there is scant evi-
dence available for the expression of Notch pathway compo-
nents at this stage (Cormier et al., 2004; Wang et al., 2004),
and no studies have addressed their differential localization. To
examine the activation status of the Notch pathway during
preimplantation stages, we used a mouse line containing a
CBF:H2B-Venus reporter, which contains multiple RBPJ binding
sites driving the expression of a nuclear-targeted Venus fluores-
cent protein and that faithfully reports the activation state of themental Cell 30, 410–422, August 25, 2014 ª2014 Elsevier Inc. 411
Figure 1. A cis-Regulatory Element Upstream of Cdx2 Drives Restricted Expression in the Trophectoderm
(A–D) H2BmRFP reporter expression driven by the Cdx2 trophectoderm enhancer (TEE) at (A) the noncompacted eight-cell stage, (B) compacted eight-cell
morula stage, (C) 16-cell stage, and (D) blastocyst stage. H2BmRFP was detected by immunohistochemistry, and nuclei were stained with DAPI. Scale
bars, 10 mm.
(legend continued on next page)
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Figure 2. The Hippo Pathway Is Not Suffi-
cient to Regulate the Cdx2 TEE
(A and B) TEE activity (red) and TEAD4 im-
munodetection (green) in (A) wild-type (WT) and (B)
Tead4 knockout embryos (Tead/). Nuclei were
stained with DAPI (blue). Maximal projections
(max. proj.) of merged images are shown in the
right panels.
(C) Immunohistochemistry for CDX2 (green) in two
Tead4mutant embryos from the same litter. Nuclei
were stained with DAPI (blue). Scale bars, 10 mm.
(D) Relative expression of Cdx2, Oct4, and Nanog
in the 5TVER7 cell line in response to tamoxifen
(Tx) induction in EMFI-CM medium of TEAD4-
mediated transdifferentiation of ES to TS cells,
compared to ES medium (ESM).
(E) Percentage of 5TVER7 cells that activate the
TEE in response to tamoxifen (Tx) induction in
EMFI-CM medium of TEAD4-mediated trans-
differentiation of ES to TS cells. Data are
means ± SEM. n = 3. **p < 0.01, *p < 0.05 by
Student’s t test compared to empty.
(F) TEE activity (red) and GFP expression (green) in
blastocysts injected with Lats2-GFPmRNA. White
arrowheads mark TEE+ nuclei in which Lats2-GFP
is expressed. Nuclei were stained with DAPI
(blue). A merged image is shown in the right panel.
See also Figure S2.
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few cells at the eight-cell stage, and activity became progres-
sively restricted to outer cells by the 3.5 dpc blastocyst stage
(Figures 3A–3C). Treatment of embryos from this line with the
g-secretase inhibitor RO4929097 (RO), a well-characterized(E) Quantification of the number of TEE-positive cells (y axis) per embryo, staged by total cell number (x ax
the bar and whiskers indicate means and SD.
(F) Correlation of TEE activity with endogenous CDX2 protein expression at the eight-cell (n = 24; three em
Individual blastomeres were scored for H2BmRFP and CDX2 immunostaining.
See also Figure S1.
Developmental Cell 30, 410–422and widely used tool that interferes with
Notch signaling by blocking the process-
ing of the receptor (Mu¨nch et al., 2013),
resulted in a strong downregulation of
the reporter (Figure 3D). We next exam-
ined the distribution by immunofluores-
cence of the endogenous NOTCH1 intra-
cellular domain (N1ICD), finding that it is
localized to the nucleus only in the outer
cells of the blastocyst (Figures 3E and
S3B). Together, these data show that
the Notch signaling pathway is active
specifically in the developing TE.
The TE Enhancer Contains
Functional RBPJ and TEAD Binding
Sites
To investigate the function of the sites
identified in the TEE, we transfected
HEK293 cells with the wild-type minimal
TEE and versions mutated in the RBPJsites alone (TEERBPJmut), the TEAD sites alone (TEETEADmut),
or in the RBPJ and the TEAD sites (TEERBPJ/TEADmut) (Figure 4A).
We then tested their response to constitutively active forms of
N1ICD (Kopan et al., 1994) and TEAD4 (Tead4VP16) (Nishioka
et al., 2009), expressed either alone or in combination. Whereasis). Each dot represents an individual embryo, and
bryos) and 16-cell stages (n = 80; five embryos).
, August 25, 2014 ª2014 Elsevier Inc. 413
Figure 3. The Notch Signaling Pathway Is
Active in the Trophectoderm
(A–C) CBF:H2B-Venus reporter expression (green)
at (A) the noncompacted eight-cell stage, (B)
morula stage, and (C) blastocyst stage.
(D) Treatment of embryos form the CBF:H2B-
Venus line with the g-secretase inhibitor
RO4929097 (RO) downregulates reporter activity
as compared to controls (DMSO).
(E) Immunodetection of Notch1 intracellular
domain (N1ICD, red). Nuclei were stained with
DAPI. Scale bars, 10 mm.
See also Figure S3.
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did not (Figure 4B), demonstrating that this regulatory element is
a transcriptional target of the Notch pathway. Tead4VP16 alone
did not affect the wild-type TEE, consistent with the results from414 Developmental Cell 30, 410–422, August 25, 2014 ª2014 Elsevier Inc.5TVER7 ES cells (Figure 2E); however,
it was sufficient to transactivate the
TEERBPJmut version (Figure 4B). This
suggests that TEAD4 acts together with
N1ICD/RBPJ to activate the TEE but
cannot activate it when RBPJ is bound
in the absence of N1ICD (and thus acts
as a repressor [Lai, 2002]). Mutation of
the RBPJ sites lifts this restriction, allow-
ing transactivation of the TEE by TEAD4.
The TEETEADmut or TEERBPJ/TEADmut
versions did not respond to either factor
(Figure 4B). Surprisingly, transgenic em-
bryos carrying the TEERBPJmut or the
TEETEADmut version retained TE lineage-
restricted activity (Figures 4C–4E),
whereas TEE activity was abolished
when the RBPJ and TEAD sites were
both mutated (Figure 4F). The lack of
response of the TEETEADmut to N1ICD
in vitro, while retaining activity in vivo sug-
gests that TEAD sites are critical for
enhancer activity in HEK cells, but not in
the blastocyst.
To confirm the function of the identified
bindingsites,wecombinedmicroinjection
of the mutated TEE versions for binding
sites of one pathway with pharmacolog-
ical disruption of the other (Figure 4G).
To disrupt the Notch pathway, we treated
microinjected embryos with RO, that as
shown above blocks Notch activity in the
TE (Figure 3D). As for the Hippo pathway,
we used Verteporfin (VP), a small mole-
cule that inhibits TEAD-YAP association
(Liu-Chittenden et al., 2012). To confirm
that VP disrupts Hippo signaling as ex-
pected, we treated embryos from the
mRFP reporter lineandexamined reporter
activity together with endogenous CDX2
expression (Figure S4A). A high percent-
age of VP-treated embryos phenocopiedTead4/ embryos (Figure 2B), with strong reduction of CDX2
but TEE activity still present (Figure S4A).
As expected, treatment of TEERBPJmutmicroinjected embryos
with RO or TEETEADmut microinjected embryos with VP had no
Developmental Cell
Role of Notch in Trophectoderm Specificationsignificant effect on TE specificity of reporter activity (Figures 4H,
S4B, and S4C). RO treatment of TEETEADmut microinjected em-
bryos strongly reduced the number of transgenic embryos
showing TE-specific expression compared to controls microin-
jected with TEETEADmut and incubated with DMSO or with
wild-type TEE treated with RO (Figures 4H and S4B). This result
confirms that attenuation of Notch signaling diminishes activity
of a TEE that lacks functional TEAD sites.
In the converse experiment, treatment with VP of embryos
microinjected with the TEERBPJmut significantly reduced TE
specificity, as compared to controls incubated with DMSO or
with wild-type TEE treated with VP (Figures 4H and S4C). This
shows that interfering with the transcriptional activity of YAP
and TEAD4 when the TEE RBPJ sites are missing decreases
enhancer activity.
Taken together, these results show that transcriptional inputs
from both pathways are responsible for full enhancer activity
through the specific binding sites identified, acting in a redun-
dant fashion in vivo.
Notch and Hippo Pathways Converge on Cdx2
Regulation
To further explore the regulation of the TEE by Notch, we tested
its activity in the absence of Notch signaling by breeding the
mRFP-TEE line in the Rbpj KO background (Oka et al., 1995).
Consistent with the activity of TEERBPJmut in the TE (Figure 4D),
Rbpj+/ and Rbpj/ embryos showed normal TEE-driven
expression, as is the case for Tead4+/ embryos (Figures 5A–
5C). These embryos also had normal numbers of cells and of
TEE+ blastomeres, although Rbpj/ embryos showed a
possible but statistically nonsignificant tendency to have fewer
TEE+ cells than didWT embryos (Figure S5A). To test for interac-
tion between theNotch andHippo on the TEE, we generated em-
bryos in the mRFP-TEE line containing different combinations of
Tead4 and Rbpj mutant alleles (Figures 5D and 5E). Double het-
erozygote embryos (Rbpj+/;Tead4+/) contained significantly
fewer than did normal TEE+ cells (Figures 5D and S5A), and
this effect was more marked in Rbpj/;Tead4+/ embryos,
where only a few mRFP cells were detected in the TE (Figures
5E and S5A). This was not due to disruption of overall cell num-
ber or the inside-outside distribution of blastomeres in these em-
bryos, as these parameters showed no significant difference
compared with wild-type, Tead4+/, Rbpj+/, or Rbpj/ blasto-
cysts (Figure S5B). Furthermore, we observed no difference in
the total number of CDX2+ cells per embryo in the different
genotypes (Figure S5B), detecting outer blastomeres that ex-
press CDX2, but not the reporter (Figures 5C–5E, arrowheads).
Unexpectedly, we did not recover any double homozygote
knockout embryos at 3.5 dpc (Figure S5C), suggesting that the
combined lack of these two factors causes the death of embryos
at an earlier stage.
We next investigated whether Notch was required for endog-
enous levels of Cdx2 expression. Quantification of CDX2 protein
per blastomere revealed significantly below-normal expression
in Rbpj/, Rbpj+/;Tead4+/, and Rbpj/;Tead4+/ embryos,
but not in Rbpj or Tead4 single heterozygotes (Figure 5F). The
effect of Notch on Cdx2 expression was confirmed by treating
embryos from the two-cell to blastocyst stages with the g-secre-
tase inhibitor RO, which significantly decreased mRNA expres-Developsion of Cdx2, but not of Oct4 or Nanog. We also examined
changes in expression of other TE-expressed genes, finding
that neither Gata3 nor Eomes changed significantly (Figure 5G),
suggesting a specific requirement of Notch for Cdx2 expres-
sion. Notch on its own does not impact events downstream or
parallel to Cdx2 function, what could be explained by the
earlier requirement of Cdx2 as compared to Gata3 and Eomes
(Ralston et al., 2010; Strumpf et al., 2005) and is consistent
with Notch signaling not being strictly required for trophecto-
derm development (Souilhol et al., 2006). In line with the genetic
analysis, combined treatment of embryos from the mRFP-TEE
transgenic line with the pharmacological disruptors of both
the Notch and Hippo pathways previously used (RO+VP)
strongly reduced TEE activity and endogenous CDX2 expression
(Figure S5D).
Notch signaling and RBPJ are thus necessary for proper
expression of endogenous Cdx2 in the embryo, in cooperation
with TEAD4. Our results thus show that the Notch and Hippo
pathways act together in the preimplantation embryo, affecting
TEE activity, CDX2 expression, and embryo viability.
Notch Activation Increases CDX2 Levels and Drives
Blastomeres to the Trophectoderm
To further explore the role of Notch in trophectoderm develop-
ment, we overexpressed the active form of NOTCH1 in the blas-
tocyst by crossing a R26-stop-N1ICD-ires-EGFP line (Murtaugh
et al., 2003) with a line carrying a maternal Sox2-Cre allele (Hay-
ashi et al., 2003). Most blastocysts obtained were viable (80%;
n = 58), as shown by the presence of a blastocoele and proper
CDX2 expression in outer cells (Figures 6A and S6A–S6C).
Although this strategy predicts uniform recombination in all cells
of the blastocyst (Figure S6G), we found mosaic expression of
the reporter at 3.5–4.0 dpc (23% EGFP blastomeres; Figures
6A and 6E). The degree of mosaicism in R26-stop-N1ICD-ires-
EGFP embryos ranged from zero recombined cells to fully re-
combined blastocysts (Figures S6A–S6C). This was confirmed
by PCR detection of the nonrecombined allele in blastocysts ob-
tained from this cross (Figure S6E), and we were also able to
detect mosaic recombination using a R26-stop-YFP reporter
and the maternal Sox2-Cre allele (Srinivas et al., 2001) (Figures
S6F and S6H).
We took advantage of this mosaicism to investigate whether
activation of the Notch pathway could upregulate endogenous
Cdx2. Quantification of CDX2 staining at the blastocyst stage
showed that blastomeres overexpressing N1ICD have higher
levels of CDX2 protein (Figure 6B). The same pattern was seen
when we analyzed only outer cells (those that would normally ex-
press Cdx2) (Figure 6C). These results complement the earlier
observation of reduced CDX2 in Rbpj mutant embryos (Fig-
ure 5F), confirming that the Notch pathway directly regulates
Cdx2 expression.
In this set of experiments, we also noticed that EGFP+ blasto-
meres were more often localized to the TE (Figure 6A), so we
analyzed the spatial distribution of blastomeres overexpressing
N1ICD in more detail. Whereas EGFP blastomeres from
mosaic embryos showed an inside-outside distribution similar
to that of blastomeres from wild-type blastocysts, EGFP+ blas-
tomeres were significantly more abundant in outside positions
(Figure 6D). Analysis of individual blastocysts revealed that thosemental Cell 30, 410–422, August 25, 2014 ª2014 Elsevier Inc. 415
(legend on next page)
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Role of Notch in Trophectoderm Specificationoverexpressing N1ICD had significantly more outside cells (75%
versus 65% in wild-type embryos) and that EGFP+ cells were
overrepresented in this population compared with inside cells
(81.3% versus 64%; Figure 6E). These results indicate that blas-
tomeres in which the Notch pathway is active localize preferen-
tially to the outer TE population and that cells can be directed to
this population by forced overexpression of the active form of
Notch1.
DISCUSSION
In this study, we have dissected the transcriptional regulation of
Cdx2 in the preimplantation mouse embryo, and by character-
izing an early TE-specific enhancer, we have identified Notch
signaling as a component of the process. The role of Notch in
cell-fate decisions during development is well established
(Koch et al., 2013), but previously no function had been
described in the initial lineage choices in the early embryo,
because of the fact that no loss-of-function mutant of the Notch
pathway has a phenotypic effect on preimplantation develop-
ment (Souilhol et al., 2006). We find that Notch directly regulates
Cdx2 expression in cooperation with TEAD4 and can also influ-
ence the fate of blastomeres by driving them to outer positions
in the embryo. This cooperation is also supported by the genetic
interaction of the two pathways, as no double homozygous mu-
tants for Tead4 and Rbpj are obtained at preimplantation stages.
Although other instances of interaction between Notch and
Hippo have been described (Barry and Camargo, 2013; Ca-
margo et al., 2007; Chen et al., 2011; Graves et al., 2012; Tscha-
harganeh et al., 2013), the results of this study show that the
Hippo and Notch pathways act in parallel and converge during
the first lineage specification in the blastocyst. In this scenario,
outside cells more prone to a TE fate would have the Notch
pathway active and the Hippo pathway inactive. It is interesting
to note that inDrosophilawing epithelial cells, inactivation of Hip-
po signaling results in apical accumulation of the Notch receptor
(Genevet et al., 2009).
Compound mutants for Rbpj and Tead4 show a reduction in
the total number of TEE-positive cells, but not of CDX2-positive
cells. However, they have below-normal expression levels per
blastomeres, suggesting that additional regulatory inputs act
on Cdx2 in the blastocyst. A possible mechanism is autoregu-
lation of Cdx2 (Barros et al., 2011; Cockburn and Rossant,
2010; Niwa et al., 2005), which would maintain and stabilize
Cdx2 expression levels after initial inputs from Notch and
Tead4.Figure 4. RBPJ and TEAD Binding Sites Are Necessary for the Activity
(A) Diagram of the Cdx2 locus, showing the TEE fragment with the putative sites
(B) Luciferase activity of wild-type and mutated versions of the TEE (TEERBPJmu
N1ICD and/or TEAD4 (TeadVP16) in tissue culture assays. A construct carrying te
control. Data are means ± SEM. n = 8 (10xRBPJ), 7 (TEE), 5 (TEERBPJmut), 4 (TEET
ns, not significant.
(C–F) Activity of wild-type TEE (C), TEERBPJmut (D), TEETEADmut (E), and TEERBPJ/T
is shown for each construct (red, mRFP; blue, DAPI). Scale bars, 10 mm.
(G) Diagram of the experimental setup of inhibitor versus DMSO treatment of em
(H) Percentage of transgenic expression (TE, TE + ICM, or weak) in embryos micr
359), TEERBPJmut (n = 66/296), or TEERBPJ/TEADmut (n = 9/79) versions of the TEE a
0.01, ***p < 0.001 by chi-square test.
See also Figure S4.
DevelopSustained activity of the Notch pathway in outer cells
would ensure that they maintain a TE fate, allowing for
correct specification of blastomeres that reposition during
cell division. Therefore, the forced activation of the pathway
we achieve by overexpressing N1ICD drives cells to relo-
cate to the outside and adopt a TE fate. It could be
argued that Notch simply elevates Cdx2 levels and that this
is the trigger for cell relocation (Jedrusik et al., 2008). How-
ever, the fact that blastomeres mutant for Cdx2 can adopt an
outer position argues against this possibility (Ralston and Ros-
sant, 2008) and suggests that Notch must target other
mechanisms operating in outer cells that result in early lineage
segregation.
The Notch signaling pathway’s role in generating heterogene-
ity from an otherwise homogenous group of cells has been
extensively studied (Artavanis-Tsakonas et al., 1999). On the
other hand, it has also been shown howNotch can produce local
homogeneity in a tissue by signaling between adjacent cells
(de la Pompa and Epstein, 2012; Lewis, 1998; Neves et al.,
2011). It would be too early to speculate which of these mecha-
nisms, lateral inhibition or lateral induction, is involved in lineage
determination in the blastocyst. Future work on how pathway
components are differentially localized during preimplantation
development and on the precise timing of expression of ligands
and receptors will be key to resolve the role of Notch in TE
specification.
The early mouse embryo has been proposed to be a self-orga-
nizing system (Wennekamp et al., 2013), such that individual
cells choose their fate according to a combination of intrinsic
and extrinsic cues. In this scenario, the robustness for TE spec-
ification would be conferred through combinatorial inputs that
would initiate and refine the expression of TE factors, such as
Cdx2. The partially redundant activities of these inputs would
be integrated via regulatory elements, such as the Cdx2 TEE,
and could underlie the regulatory capacities of the mammalian
embryo and the initial stochastic lineage-specific transcriptional
programs.
The structure of the Cdx2 TE-enhancer described here can be
used to screen for cis-regulatory elements that integrate signals
from both pathways, with a similar organization of RBPJ and
TEAD sites and thereby identify other components of the TE
specification gene regulatory network. Future work will provide
information about how modulation of Notch, together with other
signaling pathways, leads to the differentiation of the totipotent
cell and how symmetry is first broken during mammalian
development.of the Cdx2 TEE
for RBPJ (blue) and for TEAD (green) and the corresponding mutated versions.
t, TEETEADmut, and TEERBPJ/TEADmut) in response to overexpression of active
n copies of a consensus RBPJ binding site (10xRBPJ) was used as a positive
EADmut), and 4 (TEERBPJ/TEADmut). **p < 0.01, *p < 0.05 by Bonferroni posttest;
EADmut (F) in transient transgenic embryos. A representative transgenic embryo
bryos from the same batch of microinjected embryos.
oinjected with the wild-type (n = 30 transgenic/150 total), TEETEADmut (n = 91/
nd treatedwith the indicated inhibitor (RO, RO49229097; VP, Verteporfin). **p <
mental Cell 30, 410–422, August 25, 2014 ª2014 Elsevier Inc. 417
Figure 5. TEE Activity and Cdx2 Expression
Require Transcriptional Inputs from Notch
and TEAD4
(A–E) TEE activity (red) andCDX2 immunodetection
(green) in (A) Tead4+/, (B) Rbpj+/, (C) Rbpj/, (D)
Rbpj+/;Tead4+/, and (E) Rbpj/;Tead4+/
mutant embryos. Nuclei were stained with DAPI.
Arrowheads in (C)–(E) indicate TEE-;Cdx2+ outer
blastomeres. Maximal projections of merged
images are shown in the right panels. Scale
bars, 10 mm.
(F) Quantified CDX2 expression in outer cells of
wild-type blastocysts (n = 89; three embryos) and in
Tead4+/ (n = 140; three embryos), Rbpj+/ (n =
128, 4 embryos), Rbpj/ (n = 150; four embryos),
Rbpj+/;Tead4+/ (n = 115; four embryos), and
Rbpj/;Tead4+/ allelic combinations (n = 159;
three embryos). Boxes span the 25th to the 75th
percentile; internal horizontal lines indicate median
values; and whiskers show minima and maxima.
***p < 0.001 by Bonferroni posttest.
(G) Relative expression of Cdx2, Gata3, Eomes,
Oct4, and Nanog in pools of 25 embryos (n = 6)
treated from the two-cell stage until blastocyst
stage with DMSO or RO. Data are means ± SEM.
**p < 0.01 by Student’s t test.
See also Figure S5.
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Construct Generation for Microinjection
Cdx2 genomic regions were amplified by PCR using bacterial artificial chromo-
some (BAC) RP245I065 as a template. This BAC covers the whole intergenic
region containing mouse Cdx2 and was obtained from the BACPAC Re-
sources Center (http://bacpac.chori.org/). The restriction enzyme strategy or
primers used for PCR, together with the lengths of corresponding amplified
fragments, were as follows: fragment #1, GTTTGGAGAGAAGAAAGGAG and418 Developmental Cell 30, 410–422, August 25, 2014 ª2014 Elsevier Inc.GGGTGAAGTGAAGAAGATCAG (5,428 bp prod-
uct size), fragment #2, 1,856 bp ApaI digestion of
fragment #1, fragment #3, 3,572 bp ApaI digestion
of fragment #1, fragment #4, TGCTAACACAA
GCTCCCTCA and AAAGCAGGGAAGAGCACT
TTA (766 bp), fragment #5, GACTGGCTGCCT
TACCAGAG and TCTTCCAAAGACGCTGGAGT
(1,487 bp), fragment #6, CACACGGATGAAT
TGTCTGG and AACAGGGACAGGTGAGATGG
(1,329 bp), fragment #7, GCCTAGGATGCTG
ACTGAGG and CCCAAGTTGGAAAGGTTTGA
(809 bp), and fragment #8, ATCTCACCTGT
CCCTGTTGG and CCCTGGGTGAAGTGAAGAAG
(1,107 bp).
As a positive control, we used the Pou5f1 distal
enhancer element (Oct4DE) (Pernaute et al., 2010;
Yeom et al., 1996). Each fragment was subcloned
in pGEM-T Easy Vector and then excised and
cloned into a modified pBluescript vector (Yee
and Rigby, 1993) containing either a lacZ reporter
gene or H2BmRFP1 reporter gene under the con-
trol of the human beta-globin minimal promoter
and including an SV40 polyadenylation signal. Con-
structs were linearized, and plasmid sequences
were removed before microinjection.
Transient Transgenic Analysis
For the generation of transient transgenics, F1
(C57Bl/6xCBA) females were superovulated toobtain fertilized oocytes as previously described (Nagy et al., 2003). Each
construct was microinjected into the pronucleus of fertilized oocytes at E0.5
at a concentration range from 3–6 ng/ml. Microinjected oocytes were cultured
in microdrops of M16 medium (Sigma) covered with mineral oil (Sigma) at
37C, 5% CO2 until the blastocyst stage.
A minimum of 50 blastocysts were used to calculate the percentage
of lacZ or H2BmRFP-positive embryos per construct. When using the
empty vector containing only the minimal promoter and the lacZ reporter
as a negative control, we routinely obtained low-level punctuated lacZ
Figure 6. Notch Regulates Cdx2 Expression
and Instructs Cells to Adopt an Outer Posi-
tion in the Blastocyst
(A) Expression of the reporter from the R26-stop-
N1ICD-ires-EGFP line (green) and CDX2 (red)
when recombined by maternal Sox2-Cre. White
arrowheads mark nonrecombined cells. Nuclei
were stained with DAPI. Scale bars, 10 mm.
(B) Quantified CDX2 expression in all N1ICD-over-
expressing (N1OE+; green) and nonoverexpressing
(N1OE) blastomeres in embryos generated from
the _R26-stop-N1ICD-ires-EGFP X \Sox2-Cre
cross (n = 313 N1OE+; 93 N1OE blastomeres/ten
embryos).
(C) Quantified CDX2 expression in outer N1OE+
(n = 247) and N1OE (n = 59) blastomeres. In (B)
and (C), boxes span the 25th to 75th percentile;
internal horizontal lines indicate median values;
and whiskers show minima and maxima. ***p <
0.001 by Student’s t test.
(D) Inside/outside distribution of all N1OE+ and
N1OE blastomeres compared with the distribu-
tion in wild-type (WT) blastomeres (n = 304; six
embryos). ***p < 0.001 by chi-square test.
(E) Distribution per embryo of inside (gray) and
outside cells (white) in wild-type (WT; n = 6) and
N1ICD-overexpressing embryos (N1OE; n = 10).
For N1OE embryos, the contribution of EGFP-
positive cells (green) to each population is also
shown.
See also Figure S6.
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cysts. For lacZ staining, blastocysts were fixed in buffer containing 1%
formaldehyde, 0.2% glutaraldehyde, 2 mM MgCl2, 5 mM ethyleneglycoltetra-
acetic acid (EGTA), and 0.02% Igepal for 5 min at room temperature.
After washes in PBS, blastocysts were transferred to X-Gal staining solu-
tion for 24 hr at room temperature in the dark. For H2BmRFP detection,
embryos were fixed in 4% paraformaldehyde for 10 min at room tempera-
ture and either analyzed for endogenous fluorescence or immunostaining.
To visualize nuclei, embryos were incubated in DAPI at 1 mg/ml (Vector
Laboratories).
Generation of TEE Mouse Lines
Three independent transgenic mouse lines where obtained for the fragment #3
TEE constructs linked to each lacZ or H2BmRFP. All lines reproduced the TE-
restricted expression pattern in early preimplantation stages. Genotyping was
performed by PCR with primers SV40 (TCACTGCATTCTAGTTGTGG) and
50-rev comp (CTGATCTTCTTCACTTCACCCAG), which generate a 150 bp
product for the TEE-lacZ lines, and 50Cdx2 (GCAGGTGGCTGATCTTCTTC)
andmRFP (GAGCCGTACTGGAACTGAGG), which generate a 900 bp product
for the TEE-H2BmRFP lines.
PCR conditions were 95C for 5 min, 35 cycles of 94C for 1 min, 60C for
1 min, and 72C for 1 min, followed by 72C for 10 min. Embryos were
collected from crosses of TEE-lacZ or TEE-H2BmRFP males with outbred
superovulated ICR females.
Mouse Breeding
The different mouse lines used are described in themain text. Adults were gen-
otyped by PCR of tail-tip DNA using primers and conditions previously
described for each line. For preimplantation embryos, genotyping was per-Developmental Cell 30, 410–42formed directly on individually isolated embryos,
after observation in culture and X-Gal or antibody
staining.
Animal procedures were approved, as appro-
priate, by the CNIC Animal Experimentation EthicsCommittee in accordance with Spanish and European regulations or by the
Toronto Centre for Phenogenomics Animal Care Committee in accordance
with guidelines from the Canadian Council for Animal Care.
Embryo Collection and Culture
For TEE mouse line characterization, E0.5 embryos were collected from
swollen ampulas, treated with hyaluronidase (Sigma) to remove cumulus
cells and cultured until the blastocyst stage at 37.5C in 5% CO2 in air,
in M16 medium (Sigma) covered with mineral oil (Sigma). For experiments
using Tead4, Cdx2, and Rbpj mutant mouse strains, E2.5 embryos were
collected by flushing the oviduct through the infundibulum and were cultured
up to blastocyst stage. For experiments with R26YFP and R26N1OE trans-
genics, E3.5 embryos were recovered by flushing uteri with M2 medium
(Sigma).
Lats2 mRNA Injection
The Lats2-GFP construct was transcribed and microinjected into two-cell
embryos of the TEE-H2B-mRFP mouse line as previously described (Cock-
burn et al., 2013). After injection, embryos were cultured up to the blastocyst
stage.
Immunohistochemistry of Preimplantation Embryos
Immunohistochemistry was performed as previously described (Dietrich and
Hiiragi, 2007). The following antibodies and dilutions were used: monoclonal
mouse anti-CDX2 (MU392-UC, BioGenex) 1:200, rabbit polyclonal living
colors DsRed (632496 Clontech) 1:500, rabbit polyclonal living colors GFP
(632460 Clontech) 1:200, mouse anti-TEAD4 (ab58310 Abcam) 1:100, and
rabbit anti-Cleaved NOTCH1 (Val1744) (2421, Cell Signaling Technology)
1:100. Cleaved NOTCH1 was also immunodetected with amplification of2, August 25, 2014 ª2014 Elsevier Inc. 419
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PerkinElmer). Nuclei were visualized by incubating embryos in DAPI at 1 mg/ml.
Pharmacological Inhibitor Treatments
Two or four-cell embryos were cultured in drops of M16 medium (Sigma)
covered with mineral oil (Sigma) at 37C, 5% CO2, containing the correspond-
ing pharmacological inhibitor or control (DMSO) until the blastocyst stage. The
following inhibitors and concentrations were used: 10 mM of the g-secretase
inhibitor RO4929097 (S1575, Selleckchem) (Mu¨nch et al., 2013) and 2.5 mM
of the TEAD/YAP inhibitor Verteporfin (Sigma) (Liu-Chittenden et al., 2012).
Cell Culture
5TVER7-ES cells were cultured on gelatin-coated dishes with 1,000 U/ml LIF
(ESGRO-LIF; Millipore) as previously described (Nishioka et al., 2009).
Tead4VP16ER was induced by incubation of cells for 48 hr with 4-hydroxyta-
moxifen (Sigma) at 0.1 mg/ml in EMFI-CM medium (Tanaka et al., 1998) in the
presence of FGF4 (1:1,000 dilution; R&D Systems) and 1 mg/ml heparin
(Sigma). Cell transfections were performed with Lipofectamine 2000 (Invitro-
gen) and 400 ng DNA (eGFP, empty vector, Oct4DE, or TEE), followed by
growth for 48 hr.
Quantitative PCR
RNA was isolated from 5TVER7 cells with the RNeasy Mini Kit (QIAGEN) and
then reverse transcribed using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). For g-secretase inhibitor experiments, RNA from
pools of 25 embryos was isolated using the Arcturus PicoPure RNA Isolation
Kit (Applied Biosystems) and reverse transcribed using the Quantitect Kit
(QIAGEN). cDNA was used for qPCR with Power SYBR Green (Applied Bio-
systems) in a 7900HT Fast Real-Time PCR System (Applied Biosystems).
Expression of each gene was normalized to the expression of the house-
keeping genes Actin and Ywhaz (Vandesompele et al., 2002). The following
primers were used: Actin, CAGAAGGAGATTACTGCTCTGGCT (forward) and
TACTCCTGCTTGCTGATCCACAT (reverse), Cdx2, TCAACCTCGCCACAACC
TTCCC (forward) and TGGCTCAGCCTGGGATTGCT (reverse), Eomes,
TTCACCTTCTCAGAGACACAGTTCAT (forward) and GAGTTAACCTGTCATT
TTCTGAAGCC (reverse), Gata3, GGGTTCGGATGTAAGTCGAG (forward)
and CCACAGTGGGGTAGAGGTTG (reverse), Nanog, CTTACAAGGGTCTG
CTACTGAGATGC (forward) and TGCTTCCTGGCAAGGACCTT (reverse),
Oct4, ATCAGCTTGGGCTAGAGAAGGATG (forward) and AAAGGTGTCC
CTGTAGCCTCATAC (reverse), and Ywhaz, CGTTGTAGGAGCCCGTAGGT
CAT (forward) and TCTGGTTGCGAAGCATTGGG (reverse).
Mutagenesis
Mutated versions of fragment #6 (TEERBPJmut, TEETEADmut, and TEERBPJ/TEAD
mut) were generated by site-directedmutagenesis (Mutagenex). RBPJ binding
sites were located according to the consensus motif and changes that abolish
binding were made as described (Tun et al., 1994). TEAD binding sites were
based on the MCAT consensus motif (50-CATTCCA/T-30) (Anbanandam
et al., 2006). The following changes were introduced: RBPJ binding sites
TTCCCACCG to TTCggACCG, TGTGGGAAA to TGTccGAAA, TTCCCAGGT
to TTCggAGGT, and TTCCCACTT to TTaggACTT, as well as the TEAD binding
sites AATTCCTA to AcggaaTA and ATTCCAG to cggaaAG. Lowercase indi-
cates the altered residues.
Luciferase Assays
To generate the pGL3prom-TEE, pGL3prom-TEERBPJmut, pGL3prom-
TEETEADmut, and pGL3prom-TEERBPJ/TEADmut constructs, the wild-type and
mutated versions of the 1.3 kb TEE sequence were subcloned into the SacI/
SmaI sites of the pGL3-Promoter Vector (Promega).
HEK293 cells were seeded at a density of 1.53 105 cells per well on 24-well
plates 24 hr before transfection. They were then transfected using
Lipofectamine2000 (Invitrogen) with the appropriate DNA mix containing
pGL3prom-TEE (280 ng), pGL3prom-TEERBPJmut (280 ng), pGL3prom-
TEETEADmut (280 ng), pGL3prom-TEERBPJ/TEADmut (280 ng), pGL3-10xRBPJ
(McKenzie et al., 2005) (280 ng), N1ICD (100 ng), or Tead4VP16 (Nishioka
et al., 2009) (100 ng). pGL3-Renilla (20 ng) was included in all cases.
Twenty-four hours after transfection, firefly and Renilla luciferase activities
were measured using the Dual Luciferase Assay System (Promega). Data420 Developmental Cell 30, 410–422, August 25, 2014 ª2014 Elsevieare expressed as ratios of firefly to Renilla luciferase activities. Experiments
were performed in quadruplicate. Data were normalized to the basal activity
of pGL3-10xRBPJ.
Imaging and Quantification
Confocal images of microinjected or antibody-stained embryos were acquired
with a Leica SP5 confocal microscope. Images were acquired with a 633
objective and 23 zoom every 2.5 mm. Images of lacZ-stained embryos were
obtained with a Leica DMIRE2 inverted microscope. Images were prepared
for figures using Adobe Photoshop CS5.
For quantification, unmodified images were analyzed as previously
described using IMARIS imaging software (v. 7.6.3) (Bitplane) (Dietrich and
Hiiragi, 2007), with some modifications. Nuclei were segmented in 3D recon-
structions based on DAPI staining with an 8 mm isosurface. After computer
segmentation, segments were visually inspected and corrected when
necessary. The number of nuclei staining positive for TEE, CDX2, or GFP
was evaluated visually (eight-cell stage embryos) or by segmentation
(IMARIS software; E2.5 to E4.5). CDX2 protein level was estimated from
unmodified mean fluorescence intensities within segmented nuclei. Mean
DAPI fluorescence intensity was used to minimize error caused by staining
and confocal imaging variability. CDX2 intensity values for each blastomere
were normalized to the mean DAPI fluorescence intensity for each nucleus,
and these ratios were normalized to the average mean DAPI intensity per
whole embryo.
Statistics
Statistical analyses were performed with GraphPad Prism 5. Data are pre-
sented as means ± SEM or ± SD as indicated in the figures. Differences
were considered statistically significant at p < 0.05. p values were calculated
by t test for comparisons of two groups and ANOVA with Bonferroni posttest
for multiple pairwise comparisons. For the data presented in Figures 4H, 6D,
and 6E, a chi-square test was performed. All data used for quantitative analysis
are supplied in Table S1.
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